Results 271 to 280 of about 331,972 (306)
Some of the next articles are maybe not open access.
European Journal of Pharmacology, 2021
Atrial fibrillation (AF) is a common form of arrhythmia with serious public health impacts, but its underlying mechanisms are not yet fully understood. Vascular endothelial growth factor (VEGF) is highly expressed in the atrium of patients with AF, but whether VEGF affects AF pathogenesis remains unclear. Pulmonary veins (PVs) are important sources for
Jun-Hei Chang +8 more
openaire +2 more sources
Atrial fibrillation (AF) is a common form of arrhythmia with serious public health impacts, but its underlying mechanisms are not yet fully understood. Vascular endothelial growth factor (VEGF) is highly expressed in the atrium of patients with AF, but whether VEGF affects AF pathogenesis remains unclear. Pulmonary veins (PVs) are important sources for
Jun-Hei Chang +8 more
openaire +2 more sources
Critical Care Medicine, 2005
Vascular endothelial growth factor (VEGF) regulates vascular proliferation and causes vasodilation. In the pulmonary circulation, the vasorelaxing effect of VEGF has been attributed to nitric oxide, whereas in other vascular beds, prostacyclin and other mechanisms are also involved. This vascular effect follows binding to two receptors, VEGF receptor 1
Annie, Janvier +3 more
openaire +2 more sources
Vascular endothelial growth factor (VEGF) regulates vascular proliferation and causes vasodilation. In the pulmonary circulation, the vasorelaxing effect of VEGF has been attributed to nitric oxide, whereas in other vascular beds, prostacyclin and other mechanisms are also involved. This vascular effect follows binding to two receptors, VEGF receptor 1
Annie, Janvier +3 more
openaire +2 more sources
Human Pathology, 2011
Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia. Villous hypermaturity, characterized by presence of increased syncytial knots, has been associated with syndromes of placental insufficiency, particularly when severe.
Véronique, Taché +3 more
openaire +2 more sources
Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia. Villous hypermaturity, characterized by presence of increased syncytial knots, has been associated with syndromes of placental insufficiency, particularly when severe.
Véronique, Taché +3 more
openaire +2 more sources
Amniotic fluid–soluble vascular endothelial growth factor receptor-1 in preeclampsia
Obstetrics & Gynecology, 2000To measure the levels of the soluble receptor for the potent angiogenic agent vascular endothelial growth factor (VEGF) in amniotic fluid (AF) in healthy and complicated pregnancies, and compare them with levels of erythropoietin, another factor upregulated by hypoxia.We assessed amniotic fluid from the second (n = 35, gestational weeks 14-19) and ...
P, Vuorela +5 more
openaire +2 more sources
Structure and Function of Vascular Endothelial Growth Factor Receptor-1 and -2
1999Receptor-type tyrosine kinases are known to be involved in a wide variety of biological processes, such as cell growth, differentiation, morphogenesis and malignant transformation. The endothelial cell-specific growth factors, denoted vascular endothelial growth factors/vascular permeability factors (VEGF/VPF), constitute a growing family of factors ...
M, Shibuya, N, Ito, L, Claesson-Welsh
openaire +2 more sources
Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis
Critical Care Medicine, 2007To determine the putative role in the modulation of inflammation of a soluble form of Flt-1 (sFlt), a potent vascular endothelial growth factor antagonist, in experimental endotoxemia and sepsis.Randomized prospective experimental study.University medical laboratory.Male C56BL/6 strain mice.We investigated the expression patterns and the effects of ...
Po-Nien, Tsao +9 more
openaire +2 more sources
Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue
Allergy, 2013Edema represents a key feature of nasal polyp (NP) disease. Members of the vascular endothelial growth factor (VEGF) family may be involved, but the precise role of VEGF-A, VEGF-B, placental growth factor (PlGF), and their receptors VEGFR1 and VEGFR2 in NP edema formation remains elusive.Exploring the expression of VEGF family members and their ...
S, Bobic +11 more
openaire +2 more sources
Clinical Cancer Research, 2008
Abstract Purpose: Vascular endothelial growth factor (VEGF) is a key angiogenic factor mediating neovascularization. Soluble VEGF receptor 1 (sVEGFR-1) is an intrinsic negative counterpart of VEGF signaling and the ratio of sVEGFR-1 to VEGF has been shown to be a prognostic factor.
Susana, Banerjee +6 more
openaire +2 more sources
Abstract Purpose: Vascular endothelial growth factor (VEGF) is a key angiogenic factor mediating neovascularization. Soluble VEGF receptor 1 (sVEGFR-1) is an intrinsic negative counterpart of VEGF signaling and the ratio of sVEGFR-1 to VEGF has been shown to be a prognostic factor.
Susana, Banerjee +6 more
openaire +2 more sources
Journal of Periodontology, 2011
Background: The aim of this study is the evaluation of levels of serum interleukin (IL)‐1β, IL‐6, IL‐10, tumor necrosis factor (TNF)‐α, vascular endothelial growth factor (VEGF), placental growth factor (PIGF), and soluble VEGF receptor (sVEGFR)‐1 and ‐2 in the association between periodontal disease and adverse pregnancy outcomes.Methods: One hundred ...
Sert, Tuba +4 more
openaire +4 more sources
Background: The aim of this study is the evaluation of levels of serum interleukin (IL)‐1β, IL‐6, IL‐10, tumor necrosis factor (TNF)‐α, vascular endothelial growth factor (VEGF), placental growth factor (PIGF), and soluble VEGF receptor (sVEGFR)‐1 and ‐2 in the association between periodontal disease and adverse pregnancy outcomes.Methods: One hundred ...
Sert, Tuba +4 more
openaire +4 more sources
Science Signaling, 2013
Differences in how two ligands interact with VEGFR-1 explain why only one ligand is strongly angiogenic.
Anisimov Andrey +13 more
openaire +2 more sources
Differences in how two ligands interact with VEGFR-1 explain why only one ligand is strongly angiogenic.
Anisimov Andrey +13 more
openaire +2 more sources

